Case series: COVID-19 in patients with mild to moderate myasthenia gravis in a National Referral Hospital in Indonesia

BACKGROUND: During the COVID-19 pandemic, patients with myasthenia gravis (MG) are most likely to be affected by this situation. Corticosteroids and immunosuppressant agents increase the risk of severe infection. Furthermore, viral infection and some medications in COVID-19 may exacerbate MG symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Octaviana, Fitri, Yugo, Hardito Puspo, Safri, Ahmad Yanuar, Indrawati, Luh Ari, Wiratman, Winnugroho, Ayuningtyas, Triana, Hakim, Manfaluthy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898972/
https://www.ncbi.nlm.nih.gov/pubmed/33644426
http://dx.doi.org/10.1016/j.ensci.2021.100332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7898972/
https://www.ncbi.nlm.nih.gov/pubmed/33644426
http://dx.doi.org/10.1016/j.ensci.2021.100332

Ejemplares similares